Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.
SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of ...
Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...
Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...
The Global Consumer Genomics Market is primed for growth due to decreasing sequencing costs and rising health awareness, expanding from USD 2.72 Billion in 2025 to USD 8.02 Billion by 2031.
Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute. The lab enables genomic testing results to be more quickly integrated ...
BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY ® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...
(RTTNews) - Targeted Genomics LLC, creator of GlutenID—the first and only FDA-cleared direct-to-consumer genetic test for celiac disease—has entered a commercial partnership with OraSure Technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results